MAPK8 and neoplasm: We find, however, that this is likely only the case for three of the four main MAPK pathway modules in that patients with tumours that have mutations in only JNK pathway genes on average tended to exhibit significantly better disease outcomes (as adjudged by both OS and DFS) than patients with tumours that have mutations in other MAPK pathway modules (Fig. 2g).